The BC cell line MCF10DCIS.com, which forms ductal carcinoma in situ (DCIS) lesions in vivo, expresses high levels of CD44, have tumor initiating properties and are often used by researchers as a model for BC stem cells [127]. This evidence concerns the gene CD44 and ductal breast carcinoma in situ.